Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The market for gastrointestinal bleeding treatment devices is experiencing steady growth, fueled by advances in technology and increasing demand for effective treatment options. As the prevalence of gastrointestinal disorders rises worldwide, this sector is positioned for expansion, with innovations and clinical needs driving further development. Let’s explore the market size, growth factors, key segments, and competitive landscape shaping this industry.

Gastrointestinal Bleeding Treatment Devices Market Size and Growth Forecast

The gastrointestinal bleeding treatment devices market has witnessed notable expansion recently. It is projected to increase from $0.92 billion in 2025 to $1 billion in 2026, marking a compound annual growth rate (CAGR) of 8.7%. Historical growth has been driven by rising instances of gastrointestinal disorders, increased prevalence of peptic ulcer disease, the expanding use of endoscopic diagnostic procedures, more hospital-based gastrointestinal interventions, and greater availability of advanced endoscopy equipment. Looking ahead, the market is expected to reach $1.39 billion by 2030, growing at a CAGR of 8.6%. This forecast is supported by the adoption of next-generation endoscopic devices, growing demand for outpatient gastrointestinal procedures, heightened focus on early bleeding detection, the rise of ambulatory surgical centers, and increased investments in advanced gastrointestinal care technologies. Key trends expected to influence growth include greater use of advanced endoscopic hemostasis devices, minimally invasive treatment methods, precision thermal ablation tools, expanding mechanical hemostatic solutions, and a strong emphasis on rapid bleeding control.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp

Factors Contributing to the Rising Demand in the Gastrointestinal Bleeding Treatment Devices Market

One of the main reasons behind the market’s lucrative prospects is the growing burden of gastrointestinal disorders globally. Conditions affecting the digestive system are often linked to factors such as low fiber intake, high stress, insufficient water consumption, excessive dairy intake, sedentary lifestyles, aging, and genetic predispositions. For example, a report released in October 2024 by the US National Library of Medicine highlighted that in 2023, 825 per 100,000 Canadians were diagnosed with inflammatory bowel disease (IBD), affecting over 320,000 people. Projections suggest this number could rise to around 470,000 individuals, or 1.1% of the population, by 2035. This increase in gastrointestinal disease prevalence is a key driver for growth in the gastrointestinal bleeding treatment devices sector.

Detailed Segment Breakdown of the Gastrointestinal Bleeding Treatment Devices Market

This market is categorized into several segments based on product type, gastrointestinal tract division, and end user. By product, the market includes Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents and Powders, and Combination or Multimodal Hemostasis Devices. Regarding the GI tract division, the market is split into Upper GI Tract and Lower GI Tract. End users primarily consist of Hospitals or Clinics, Ambulatory Surgical Centers, and other relevant facilities. Further subcategories delve into specific device types, such as Electrocautery and Electrosurgical Coagulation Devices, Argon Plasma Coagulation Devices, Hemostatic Clips, Endoscopic Band Ligation Devices, Epinephrine Injection Systems, Hemostatic Powder Sprays, and integrated multimodal endoscopic platforms, among others.

Access The Complete Gastrointestinal Bleeding Treatment Devices Market Report:

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Innovations and Strategic Developments Defining Market Growth

Leading companies in this sector are focusing on creating advanced solutions to improve treatment outcomes. One prominent example is Hemospray, a hemostatic powder designed to control active gastrointestinal bleeding during endoscopic procedures. Notably, in January 2024, AIG Hospitals in India introduced Hemospray as a breakthrough technology for managing GI bleeding. Its ease of use, safety, and effectiveness in controlling a wide range of GI bleeds—from peptic ulcers to variceal hemorrhages—make it a significant advancement in the field.

Key Players and Competitive Landscape in the Gastrointestinal Bleeding Treatment Devices Market

The industry features several major players driving innovation and market penetration. These include CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., and Hemostasis LLC.

Regional Market Insights Highlighting Areas of Opportunity

In 2025, North America held the largest share of the gastrointestinal bleeding treatment devices market. However, the Asia-Pacific region is anticipated to exhibit the fastest growth rate during the forecast period. The market coverage extends across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and future prospects.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model